Cybin Inc. Common Stock
HELP
株式のランク
#11559
Cybin Inc. functions as a biopharmaceutical company currently in its clinical... Cybin Inc. functions as a biopharmaceutical company currently in its clinical development phase, concentrating on the advancement of novel therapeutic agents derived from psychedelic compounds. Its research pipeline includes CYB003, a deuterated psilocybin analog under investigation for major depressive disorder, and CYB004, a deuterated DMT compound being developed to address generalized anxiety disorder.
株価
$10.30
最終同期: 2026-08-11
時価総額
$638.32M
変化（1日）
2.88%
変化（1年）
9,119.52%
国
CA
取引 Cybin Inc. Common Stock (HELP)
カテゴリー
Healthcare
Cybin Inc. Common Stock（HELP）の株価履歴
終値の最高値: $0.12 （2023-10-01）
終値の最安値: $0.40 （2021-06-01）
終値の最安値: $0.40 （2021-06-01）
Cybin Inc. Common Stock の株価履歴（2021 ～ 2026）
年間株価パフォーマンス
| 年 | パフォーマンス |
|---|---|
| 2023 | 81.70% |
| 2022 | -76.32% |
| 2021 | 0.00% |
類似企業または競合の株価
| 企業 | 株価 | 変化率 1年% | 国 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $758.21 | 7.77% |
CH
|
